July 25, 2024, 10:06 am EDT
Medical, Bio-Tech, Pharmaceuticals
Medical, biotech, and pharmaceuticals will outperform others if the stock market deteriorates further in the second half of 2024. We will show three stocks in each category that may be worth attention for their potential. They have already demonstrated their strength in the past few weeks in the performance.
Medical Devices: Thermo Fisher Scientific (TMO)
Biotech: Gilead Sciences (GILD)
Pharmaceuticals: Bristol-Myers Squibb (BMY)
All these companies are well-established corporations with diversified products. We are considering adding some of them to our watchlist or portfolio to fight over the fierce battlefield of the downtrend markets in the future.
